Literature DB >> 9597221

Clostridium difficile--associated diarrhea.

S Johnson1, D N Gerding.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597221     DOI: 10.1086/520276

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  89 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Renate J van den Berg; Lesla S Bruijnesteijn van Coppenraet; Hendrik-Jan Gerritsen; Hubert P Endtz; Eric R van der Vorm; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin.

Authors:  Anita P Borek; Deborah Z Aird; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 4.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

5.  Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Authors:  A Lozniewski; C Rabaud; E Dotto; M Weber; F Mory
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.

Authors:  M L Landry; J Topal; D Ferguson; D Giudetti; Y Tang
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

7.  Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.

Authors:  Andrada Seicean; Anca Moldovan-Pop; Radu Seicean
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 8.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

9.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

10.  Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.

Authors:  Judith Maria Wenisch; Susanne Equiluz-Bruck; Marta Fudel; Ingun Reiter; Andrea Schmid; Erna Singer; Andreas Chott
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.